Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
154.60
+5.04 (+3.37%)
Streaming Delayed Price
Updated: 11:09 AM EDT, Jul 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,209,454
Open
155.39
Bid (Size)
154.50 (100)
Ask (Size)
154.60 (100)
Prev. Close
149.56
Today's Range
153.66 - 159.30
52wk Range
112.34 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.09%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novartis Q2 Earnings Call Highlights
↗
Today 11:07 EDT
Novartis (NYSE:NVS) said it returned to sales growth in the second quarter of 2026, supported by strong gains across priority medicines and launches, while reaffirming its full-year outlook despite...
Via
MarketBeat
Topics
ETFs
Earnings
Novartis Q2 2026 Earnings Call Transcript
↗
Today 9:45 EDT
Novartis (NYSE:NVS) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access...
Via
Benzinga
Topics
Earnings
Performance
YTD
+11.6%
+11.6%
1 Month
+3.8%
+3.8%
3 Month
+2.4%
+2.4%
6 Month
+7.7%
+7.7%
1 Year
+35.4%
+35.4%
More News
Read More
Novartis Bounds For Buy Point. Why Shares Are On The Rise.
↗
Today 8:48 EDT
Via
Investor's Business Daily
Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline
↗
Today 8:21 EDT
Via
Benzinga
NOVARTIS AG-SPONSORED ADR (NYSE:NVS): High-Quality Dividend Stock With Strong Profitability and Sustainable Payout
↗
July 07, 2026
Via
Chartmill
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
↗
July 20, 2026
Via
The Motley Fool
Topics
ETFs
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval
↗
July 17, 2026
Via
Benzinga
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
July 14, 2026
Via
Newsfile
Global Nitrogen-Containing Bisphosphonate Drugs Market Growing at 3.1% CAGR Through 2032
↗
July 14, 2026
Via
Talk Markets
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
↗
July 09, 2026
Via
The Motley Fool
What Is the Vanguard International Dividend Appreciation ETF (VIGI), and Who Should Buy It?
↗
July 09, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
↗
July 09, 2026
Via
The Motley Fool
Topics
ETFs
VYMI vs. VIGI: Which International Dividend ETF Is Better?
↗
July 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
2 Fast-Growing Pharmaceutical Stocks to Buy Now
↗
July 08, 2026
Via
The Motley Fool
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
↗
July 08, 2026
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Stocks
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
July 06, 2026
Via
Investor Brand Network
Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push
↗
July 06, 2026
Via
Benzinga
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
↗
July 04, 2026
Via
The Motley Fool
Topics
ETFs
New Research Says: The Biggest Gains of AI Won't Go to AI Stocks. These 2 ETFs Could Be Better Buys.
↗
July 04, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand.
↗
July 02, 2026
Via
The Motley Fool
Topics
ETFs
3 European Stocks to Carry Investors Through the Back Half of 2026
↗
July 01, 2026
Via
MarketBeat
Topics
ETFs
Stocks
Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston
June 29, 2026
Via
Press Release Distribution Service
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
↗
June 29, 2026
Via
The Motley Fool
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal
↗
June 24, 2026
Via
Benzinga
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
Via
Investor Brand Network
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 154.60
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 07/21/26 11:09 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.